ASX ANNOUNCEMENT Medical Developments International Limited (ASX:MVP) has received approval from the Medicines Control Council (MCC) in South Africa to market and sell its inhaled analgesic product, ‘Penthrox’ for pain relief from trauma and surgical procedures. The approval gives MVP’s partner in South Africa, LINK Healthcare Pte Ltd (through its wholly owned subsidiary Equity Pharmaceuticals

Link Healthcare secures marketing approval for ALLMERCAP™ for the treatment of acute lymphoblastic leukaemia (ALL) the product is an oral suspension of current ALL treatment, mercaptopurine ALLMERCAP’s child-friendly formulation offers more accurate dosing than tablets LINK has partnered with Nova Laboratories, UK to make the drug available in Australia Sydney/Pretoria/Singapore/Tokyo/Auckland: 16 June 2014. Specialist pharmaceutical